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Abstract
Background—Oxidative stress occurs through free radical- and non-radical-mediated oxidative
mechanisms, but these are poorly discriminated by most assays. A convenient assay for oxidants
in human serum is based upon the Fe2+-dependent decomposition of peroxides to oxidize N,N′-
diethyl-1,4-phenylenediamine (DEPPD) to a stable radical cation which can be measured
spectrophotometrically.
Methods—We investigated modification of the DEPPD oxidation assay to discriminate color
formation due to non-radical oxidants, including hydroperoxides and endoperoxides, which are
sensitive to ebselen.
Results—Use of serum, which has been pretreated with ebselen as a reference, provides a
quantitative assay for non-radical, reactive oxidant species in serum, including hydroperoxides,
endoperoxides and epoxides. In a set of 35 human serum samples, non-radical oxidants largely
accounted for DEPPD oxidation in 86% of the samples while the remaining 14% had considerable
contribution from other redox-active chemicals.
Conclusions—The simple modification in which ebselen-pretreated sample is used as a
reference provides means to quantify non-radical oxidants in human serum. Application of this
approach could enhance understanding of the contribution of different types of oxidative stress to
disease.
© 2012 Elsevier B.V. All rights reserved.
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1. Introduction
Circumstantial evidence indicates that oxidative stress is a component of many chronic and
age-related diseases, yet evidence from large-scale, double-blind interventional trials with
the free radical-scavenging antioxidants, vitamins C and E, provides little support for
involvement of free radical mechanisms [1]. An alternative hypothesis is that the
quantitatively important oxidative reactions contributing to disease involve non-radical
oxidant species, such as peroxides, which disrupt redox signaling and control mechanisms
[2]. However, distinction between radical and non-radical mechanisms of injury is
technically challenging, especially when both free radicals and non-radical oxidants are
present in a biologic system.
Another difficulty concerns the nature of oxidants relevant to disease risk. Although much
of the oxidative stress literature focuses on highly reactive oxygen species (ROS) which are
short-lived in biologic systems, many studies show that there are relatively stable oxidants
which persist in human serum even after months of storage at -80° C. The latter have been
termed “reactive oxygen metabolites”, for which we use the generic term “ROM” in the
present manuscript. ROM in serum can be operationally defined by a reaction with N,N
′diethyl-para-phenylenediamine (DEPPD) in the presence of Fe2+, which produces a stable
radical cation (Fig. 1A) easily measured using a spectrophotometer because it is a red
chromophore [3].
This reaction is the basis for the popular d-ROMs assay (Diacron International, Italy;
www.diacrom.com) [3] and similar FORT (Free Oxygen Radicals Test; INCOMAT
Mediznische, Glashutten, Germany). These tests are simple, relatively inexpensive and have
been widely used to measure oxidative stress in human serum [4-11]. Importantly, the
results of studies from different research groups suggest that these tests could be useful to
assess disease risk. Such use is limited by uncertainty about the chemical nature of ROM.
The ROM test is standardized relative to tert-butylhydroperoxide or H2O2, giving the
impression that the test is measuring H2O2 and organic peroxides in serum. However, H2O2
and many hydroperoxides are relatively unstable and would not be expected in serum at
concentrations indicated by the DEPPD reaction. Moreover, background chromophores as
well as other oxidative reactions, e.g., ceruloplasmin activity [3] can contribute to the
spectral change. Use of an EDTA-containing blank can correct for background
chromophores; however, EDTA inhibits both peroxide-dependent color formation and
ceruloplasmin activity so that an EDTA control does not discriminate factors contributing to
the DEPPD oxidation by serum.
Antioxidants, such as butylated hydroxytoluene, added to serum could block DEPPD
oxidation, but would not discriminate between the types of oxidants present in the sample.
In the present study, we examined whether ebselen, a selenium-containing chemical which
reduces peroxides in the presence of thiols [12], could be used to improve the specificity of
the DEPPD reaction for peroxides in human serum. Ebselen, 2-phenyl-1,2-
benzisoselenazol-3(2H)one (Fig. 1B), catalyzes thiol-dependent reduction of peroxides by a
non-radical mechanism [12,13]. Although earlier literature suggested that ebselen has
properties such as free radical quenching [12], this activity was subsequently shown to have
little effect [14]. Sequential reduction of ebselen by glutathione produces a selenol which is
the direct reductant for the peroxides [13].
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The present research shows that ebselen pretreatment of serum largely eliminates the serum-
dependent oxidation of DEPPD. Studies with a purified endoperoxide and two epoxides
show that, in addition to previously characterized oxidation of DEPPD by hydroperoxides,
both of these oxidants support the DEPPD oxidation reaction and are eliminated by
pretreatment with ebselen. Use of an imidazole N-oxide to trap radicals provided further
evidence that the radical products are derived from non-radical species. Thus, use of an
ebselen-pretreated serum sample as a reference for the DEPPD-dependent
spectrophotometric assay provides means to improve specificity for non-radical oxidants in
serum. This simple, yet novel, approach provides means to discriminate ebselen-dependent
and ebselen-independent oxidative mechanisms that contribute to the DEPPD signal and
potentially can be useful for population studies to test for distinct associations of disease risk
with non-radical and radical mechanisms.
2. Materials and Methods
2.1 Materials
N,N-diethyl-1,4-phenylenediamine (DEPPD), tert-butylhydroperoxide (tBH), FeSO4,
bathocuproine disulfonate (BCDS), glutathione peroxidase (bovine erythrocyte, Gpx),
catalase, microsomal epoxide hydrolase (human, EH), rhodococcus epoxide hydrolase
(EHr), styrene oxide, and 16,17-epoxy-21-acetoxy-pregnenolone were from Sigma-Aldrich
(St Louis, MO). Prostaglandin H2 (PGH2) was from Cayman Chemical (Ann Arbor, MI).
Peroxiredoxin-1 (human) was purchased from Lab Frontier (Seoul, South Korea). Ebselen
[yl-1,2-benzisoselenazol-3(2H)one]urchased from Alexis Biochemicals (San Diego, CA).
Other chemicals were of reagent grade and purchased locally.
Human studies were conducted with approval of the Emory University Investigational
Review Board. Some serum samples for methods development were obtained commercially.
2.2 Methods
Experimentation was performed in 4 parts, with the goals to 1) adapt the DEPPD assay as
developed by Alberti et al. [3] to a 96-well plate format and test it against a commercially
available kit, 2) use selective chemical reactivity and enzymatic activity to gain information
on the chemical nature of ROM in serum and 3) test model endoperoxide and epoxides to
determine whether these classes of chemicals could be components of ROM in plasma and
4) compare the original Alberti assay to those obtained using an ebselen blank to determine
whether this modification could improve specificity for the assay.
The final standard protocol adapted from Alberti et al. [3] for a 96-well plate format was as
follows: Serum samples were diluted 1:40 in acetate buffer (37.32 mmol/l, pH 4.8). Five
microliter aliquots were transferred to adjacent rows in 96-well plates with 100 μl of acetate
buffer without or with 5 μl of 1 mmol/l ebselen in DMSO (50 μmol/l final concentration).
Control experiments with DMSO without ebselen showed that DMSO had no effect on the
color formation at the volume added. After 6 min at room temperature with shaking, 10 μl
of 3.9 mmol/l DEPPD with 2.8 mmol/l FeSO4 was added with a multi-channel pipette, and
samples were shaken for 6 min prior to reading absorbance at 505 nm on a multiwell
platereader. Values are reported as ΔA505 at 6 min using as reference wells which were
identically treated except for substitution of EDTA for Fe2+. The ΔA505 can be readily
converted to peroxide equivalents using the tBH standard curve or to Carr units [3], which
are arbitrary units corresponding to 0.08 mg H2O2 per 100 ml (24 μmolo/l). Where used, the
FORT kit (INCOMAT Medizinische, Glashutten, Germany) was performed according to
manufacturer's instructions.
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For studies of the chemical nature of ROM in plasma, reagents were prepared at pH 7.0 and
added to serum without adjustment of pH of the serum. Pretreated serum aliquots were then
added to acetate buffer and DEPPD was added. Absorbance was scanned over the range of
450 to 575 nm, with data reported for the scans taken at 6 min after addition of either Fe2+
or EDTA. Concentrations of agents used for pretreatments were as follows: bathocuproine
disulfonate, 1 mmol/l; Na2S, 50 μmol/l and 5 mmol/l; GSH 100 μmol/l and 5 mmol/l; Cys,
50 μmol/l and 5 mmol/l; ebselen, 0.03, 0.12, 0.5 and 1 mmol/l; microsomal epoxide
hydrolase, 0.2 mg/ml; rhodococcus epoxide hydrolase, 0.2 mg/ml; peroxiredoxin-1, 0.1 mg/
ml; glutathione peroxidase-1, 50 units/ml (dialyzed to remove dithiothreitol); catalase, 0.2
mg/ml (dialyzed to remove thymol).
Assays with peroxides and epoxides were performed under identical conditions as above,
with respective solutions replacing serum. Concentrations added were as follows: PGH2, 90
μmol/l; 16,17-epoxy-21-acetoxy-pregnenolone, 1 mmol/l; styrene oxide, 1 mmol/l. For each
experiment with purified peroxide or epoxide, a parallel experiment was performed in which
the peroxide or epoxide was added along with serum so that the experiment was conducted
with the same matrix. Results were qualitatively the same as the results shown and,
therefore, are not included.
Spin trapping experiments were performed using 4-carboxy-2,2-dimethyl-2H-imidazole-1-
oxide (CDMIO, Alexis Corp). This anionic spin trap is resistant to reduction by ascorbate
and therefore useful to trap free radicals in the serum [15]. Conditions used were 500 mmol/l
CDMIO, 200 μmol/l FeSO4, 15% (v/v) serum in acetate buffer. ESR settings were as
described previously [16].
3. Results
3.1 DEPPD-dependent color formation with human serum
Previous research showed that hydroperoxides in the presence of Fe2+ oxidize DEPPD and
that this reaction is blocked by EDTA, a metal ion chelator [3]. We initially performed
experiments to adapt the principles of the previous research to a 96-well plate format. In this
development, we observed that DEPPD oxidation occurred with serum and tert-
butylhydroperoxide (tBH) and that both were inhibited by EDTA (Fig. 2A). Time course
studies showed that two phases of oxidation were present, one which appeared as a
continuous background oxidation, perhaps due to slow oxidation of proteins, and the other
which was an oxidation complete by 6 min (Fig. 2B). At the 6-min time point, the
contribution of background oxidation was minimal and the signal due to the “pre-formed”
oxidant was maximal (Fig. 2C); thus, analyses were performed with a format in which
oxidation at 6 min was measured. Comparisons of data for 3, 5, 6, and 7 min showed that the
A505 was linearly dependent upon added tert-butyl hydroperoxide standard (7 to 120 μmol/l)
over this time frame (r2 = 0.99; Fig. 2C). A direct comparison of the 96-well plate format to
the commercial FORT kit showed that the adapted 96-well plate format provided values
equal to 101 ± 4% of the FORT assay values (Table 1). Within day CV values were 6.0 for
the FORT kit and 6.5 for the 96-well plate assay; corresponding between-day CV were 5.8
and 5.3, respectively (Table 1). Thus, the data show that the ROM test can be adapted to a
multi-well plate format which is comparable to the standardized FORT kit. This allows large
numbers of samples to be rapidly measured.
To test for the contribution of the ferroxidase activity of the copper-dependent enzyme,
ceruloplasmin, to DEPPD oxidation, we pretreated serum with the copper chelator
bathocuproine disulfonate (BCDS). Results showed that BCDS did not cause a significant
decrease in DEPPD oxidation, indicating that the timed method as described had minimal
contribution from ceruloplasmin (Fig. 3A). We next tested the effects of thiols on serum-
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dependent DEPPD oxidation. Results showed that Na2S, cysteine and GSH each prevented
the accumulation of the DEPPD cation radical. However, at low concentrations of thiols as
found in serum, no effects were observed in the assay (Fig. 2B).
Studies were performed to detect endogenous oxidants in serum which could contribute to
DEPPD oxidation. For this, we preincubated serum with catalase, GSH peroxidase-1,
peroxiredoxin-1 and epoxide hydrolase (microsomal and rhodococcus). Results showed
decreased signal for all except rhodococcus epoxide hydrolase and catalase (Fig. 3C). The
microsomal epoxide hydrolase partially decreased the signal (EH, Fig. 3C,D), but the
rhodococcus enzyme did not (EHr, Fig. 3C). GSH peroxidase-1 pretreatment effectively
eliminated the serum-dependent DEPPD oxidation (Gpx, Fig. 3C); peroxiredoxin-1
decreased but did not totally eliminate the oxidation (Prx, Fig. 3C). Catalase was dialyzed to
remove thymol and did not protect against oxidants (Cat, Fig. 3C). These data show that
peroxides, which could include hydroperoxides and endoperoxides, contribute to DEPPD
oxidation. The lack of effect of pretreatment with catalase shows that the H2O2 in serum
does not provide a significant contribution to the signal. The data suggest that epoxides
could also contribute to the signal.
To test the effect of the GSH peroxidase mimetic, ebselen, on serum-dependent DEPPD
oxidation, we performed experiments with increasing concentrations of ebselen. Earlier data
show that ebselen effectively reduces hydroperoxides by thiol-dependent mechanisms
[17,18]. Results with serum showed that ebselen pretreatment caused a concentration-
dependent loss of signal (Fig. 4A). Time course studies showed that the effect was time-
dependent; simultaneous addition of ebselen with DEPPD did not completely block color
formation, while pretreatment with 1 mmol/l gave essentially complete inhibition (Fig.
4B,C). Addition of ebselen after formation of color had no effect (Fig. 4B), indicating that
ebselen does not reduce the DEPPD radical cation but rather eliminates oxidants which
contribute to DEPPD oxidation.
To further test the characteristics of ebselen-sensitive oxidants detected by DEPPD, samples
were analzed by ESR spectroscopy using CDMIO as a spin-trapping agent [15]. CMDIO is a
2H-imidazole-1-oxide which traps C- and O-centered radicals and is well suited for studies
of radical species in serum because it is not reduced by ascorbate. Figure 4D shows a typical
ESR spectrum of free radical detection by CDMIO in the presesnce of tert-
butylhydroperoxide + Fe2+ in which both C- and O-centered radical adducts are identified.
An ESR spectrum of serum + Fe2+ +CDMIO shows mostly a signal typical of O-centered
radicals (Fig. 4E). Preincubation of serum with ebselen inhibited spin trapping of oxygen
centered radical (Fig. 3F). Because ebselen is known to have peroxidase activity and the
previous experiment with catalase (Fig. 3) showed that the peroxide is not H2O2, the results
allow the assignment as a lipid-derived alkoxyl radical (·O-L). This assignment was made
due to the fact that lipid peroxyl radicals are difficult to detect with ESR and that these
radicals will degrade to alkoxyl radicals which can be detected [19]. Of note, this lipid-
derived alkoxyl radical adduct was the major species found in the spectra; the second radical
adduct represented the spin trapping of carbon-centered radicals, which were present in a
lesser amount. Thus, ebselen pretreatment eliminates the lipid peroxides which contribute to
DEPPD oxidation by serum.
We examined whether endoperoxides could contribute to DEPPD oxidation by testing
prostaglandin H2, PGH2. Results showed that 90 μmol/l PGH2 oxidized DEPPD in the
presence of Fe2+ and that this reaction was prevented by pretreatment of PGH2 with ebselen
(Fig. 5A,B). The extent of oxidation was about half that caused by 100 μmol/l tBH (not
shown), indicating that the endoperoxide oxidizes DEPPD, but the extent of this reaction
may be about half of that provided by hydroperoxides. Thus, in addition to hydroperoxides,
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ebselen reacts with endoperoxides. Consequently, the data show that ebselen pretreatment of
serum allows detection of the sum of hydroperoxides and endoperoxides but does not allow
distinction between these forms.
As a control for the data showing that microsomal epoxide hydrolase pretreatment decreased
serum-dependent DEPPD oxidation, we pretreated PGH2 with microsomal epoxide
hydrolase. Results showed a decrease in PGH2-dependent DEPPD oxidation (Fig. 5A). The
same pretreatment with rhodococcus epoxide hydrolase had no effect (not shown). The
results are consistent with the microsomal epoxide hydrolase preparation having
endoperoxidase activity.
To test whether epoxides could contribute to DEPPD oxidation as suggested by the results
of epoxide hydrolase pretreatment of serum (Fig. 3), we measured oxidation of DEPPD by
styrene oxide and 16,17-epoxy-21-acetoxy-pregnenolone [Preg(O)]. Styrene oxide resulted
in no Fe2+-dependent DEPPD oxidation, even at 1 mmol/l concentration (data not shown).
Experiments with Preg(O) showed that oxidation of DEPPD occurred with relatively high (1
mmol/l) concentration (Fig. 5C,D). This oxidation was blocked by pretreatment with
microsomal epoxide hydrolase or ebselen (Fig. 5C,D). Consequently, one must conclude
from the data on epoxide hydrolase pretreatment of serum (Fig. 3) and direct studies with
purified epoxides (Fig. 5) that the non-radical species in serum are likely to include epoxides
but with low color yield. This indicates that comparison of ebselen pretreated samples to the
standard DEPPD oxidation assay provides a means to quantify non-radical oxidants,
including hydroperoxides, endoperoxides and possibly epoxides, but does not discriminate
between these classes of chemicals.
Although the data show that the DEPPD oxidation test measures peroxides and epoxides in
serum, the data do not show the extent to which the ebselen-dependent DEPPD signal
corresponds to the standard ROM assay described by Alberti et al. [3]. A direct comparison
of the ebselen-dependent assay for non-radical oxidant species with the original method for
DEPPD oxidation [3] is shown in Figure 6. For most samples, the methods are completely
comparable. However, considerable differences are present in 14% of the samples. The
comparable signals in most of the samples support the interpretation that the measurement of
DEPPD oxidation largely represents non-radical oxidants. The data also show that a more
specific assessment of the ebselen-dependent signal, such as by mass spectrometry, may
provide a better means to assess the contribution of non-radical oxidants to disease. In
addition, samples in which a tight association is not seen may represent a qualitatively
unique pattern of oxidants which contribute to distinct oxidant mechanisms in disease.
4. Discussion
Much of oxidative stress research has been focused on free radical mechanisms yet large-
scale interventional trials with moderately high intakes of two of the best characterized free
radical scavenging antioxidants, vitamins C and E, provided little evidence for benefit [1].
An alternative, non-radical hypothesis for oxidative stress has been proposed based upon the
evidence that free radicals represent only a small fraction of the total oxidant load [2]. In this
hypothesis, non-radical oxidants are proposed to be the quantitatively important reactive
species under many, if not most, conditions where oxidative stress contributes to disease.
Ironically, the assays based upon DEPPD oxidation, which were founded upon free radical
principles and utilize a stable radical cation to quantify oxidants, largely, according to the
data presented here, measure non-radical oxidant species in serum. The oxidation of DEPPD
to the radical cation is dependent upon Fe2+ to transfer electrons to relatively stable non-
radical oxidants in serum [3]. Under conditions of the assay, 2 oxidative phases are
apparent; the assay as described is optimized (timed assay at 5-7 min) to measure the pre-
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existing stable oxidants and to minimize the contribution of other oxidative processes. A
slower background oxidative reaction is likely to represent ongoing oxidant generation,
including those of ceruloplasmin, protein oxidation and free radical reactions.
The general agreement between the standard assay for oxidation of DEPPD by serum and
the ebselen-sensitive oxidant assay indicates that the former mostly measures non-radical
oxidants. While it is possible that ebselen could quench singlet oxygen [12], this reaction is
considered sluggish [14] and we do not consider singlet oxygen as a likely candidate for
ROM in serum. It should be noted that previous research by Hassan and colleagues has
shown that ebselen does not completely prevent Fe(II)-mediated increases in TBARS at acid
pH [20]. We did not study the pH dependence of ebselen-dependent loss of DEPPD
oxidation, but our spectral analysis and ESR data show that the signal was lost following
treatment with ebselen. Consequently, we conclude that under the conditions of the
preincubation, ebselen largely eliminated the serum-dependent oxidation of DEPPD. In this
reaction, exogenously added thiol was not required for the reduction. Because 50 μmol/l
H2S, 50 μmol/l Cys or 100 μmol/l GSH had little effect on DEPPD oxidation in the absence
of ebselen (Fig. 4), we conclude that endogenous thiol content of serum is probably <100
μmol/l, and due to the fact that the concentration of oxidants present in the serum are
typically in the nanomolar range [20-22], the 50 μmol/l concentration of ebselen used is in
significant excess and will not require thiol equivalents to recycle the antioxidant.
The present data with PGH2 shows that endoperoxides, in addition to the usually
characterized hydroperoxides, can contribute to the signal. Additional analyses of lipid
components could be conducted by using a methanol extraction and further analysis. Thus,
endoperoxides in serum are not distinguished from hydroperoxides and, if present,
contribute to the DEPPD oxidation signal. Additionally, the inability of catalase to prevent
DEPPD oxidation by serum indicates that H2O2 contributes little to the signal.
If one assumes that epoxide hydrolase is specific for epoxides, the results indicate that
approximately 50% of the non-radicals in serum are epoxides. The inhibition of PGH2-
induced DEPPD oxidation by epoxide hydrolase, however, also allows the interpretation that
epoxides contribute little to the total signal and that endoperoxides may account for the
epoxide-hydrolase-dependent signal. Additional characterization of the enzymatic
specificities of the epoxide hydrolases employed in this study, along with chemical analyses
of their products, is needed to distinguish these possibilities.
The discrepancy between analyses without and with ebselen for about 15% of the samples
(Fig. 6) indicates that some serum samples contain large amounts of redox components other
than peroxides and epoxides. This discrepancy could represent a subset with qualitative
differences in serum oxidative chemistry, i.e., ones with a high amount of free radical
reactions or oxidants which are not reactive with ebselen. Importantly, the previously
observed associations of DEPPD oxidation with disease risks could be due to the ebselen-
dependent component or the ebselen-independent component. Application of the methods as
described to population studies will allow for the discrimination of the non-radical oxidative
species in serum from the residual signal. Such analyses could be helpful in understanding
the association of ROM test results with pathologies such as cardiovascular disease and
atrial fibrillation [23, 24].
In summary, this present study validates a multi-well, microplate format for the popular
assays of reactive oxygen metabolites in human serum based upon DEPPD oxidation and an
adapted form of the assay in which ebselen is used to eliminate non-radical oxidants. The
non-radical oxidants include hydroperoxides, endoperoxides and possibly epoxides, but the
assay does not discriminate between these oxidative species.
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A relatively small subset of samples had a discordant response between assays with and
without ebselen, which could represent a qualitatively distinct form of oxidant in these
samples. Finally, we conclude that the ROM tests, including commercial kits based upon the
same principles, largely measure non-radical reactive oxygen metabolites (NR-ROM) and
that the specificity of the test for measuring NR-ROM can be improved by using
corresponding ebselen-pretreated samples as references. This adaptation can allow for high
throughput ROM analyses and application of this assay to population studies may, therefore,
provide an approach to distinguish risks associated with non-radical and radical oxidative
components of human serum.
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• We modified a simple assay in order to distinguish non-radical from radical
species
• Human serum was pretreated with ebselen to determine non-radical involvement
• Non-radical species largely account for derum-mediated DEPPD oxidation
• This assay can enhance understanding of contribution of different oxidants to
disease
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(A) The reaction between a free radical and DEPPD results in the formation of a stable
radical that can be measured at absorbance of 505 nm. (B) The multi ring structure of the
antioxidant, ebselen.
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Adapatation of DEPPD oxidation assay of serum oxidant to a 96-well plate format. Ferrous
iron-dependent oxidation of DEPPD by serum was assayed using conditions of Alberti et al.
[3] and compared to oxidation by 50 μM tert-butylhydroperoxide (tBH). A) Absorbance
scan from 450 to 575 nm performed 6 min after addition of serum or tBH. Results are shown
without and with 1 mmol/l EDTA. B). Time course of reaction measured at 505 nm showed
that the color change appeared to occur with 2 phases, a rapid phase which was maximal at 6
min and a slow phase which was linear with time. C) Standard curves performed with tBH at
different timed intervals showed that the DEPPD oxidation was linearly dependent upon
tBH and was not significantly different for times of 5-7 min. Thus, a standard assay time of
6 min was selected to approximate maximal signal from the initial phase oxidation while
maintaining a minimal contribution from the slow phase oxidation. Data from representative
experiment; similar results were obtained using sera from 4 individuals.
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Factors affecting serum-dependent oxidation of DEPPD. A) Serum samples were assayed
for DEPPD oxidation with 1 mmol/l of the specific copper chelator, bathocuproine
disulfonate (BCDS). B) Serum samples were assayed for DEPPD oxidation with either 5
mmol/l or 50 μM Na2S, 5 mmol/l or 50μM GSH or 2 mmol/l or 50 μM cysteine (Cys). C)
Serum samples were assayed for DEPPD oxidation with microsomal epoxide hydrolase
(EH), rhodococcus epoxide hydrolase (EHr), peroxiredoxin-1 (Prx), glutathione
peroxidase-1 plus 50 μmol/l GSH (labeled Gpx) and catalase (Cat). D) Spectral analysis of
reaction following pretreatment of serum with microsomal epoxide hydrolase (EH). EDTA-
treated control is shown for reference. Spectra are representative for at least 3 individuals.
Other data are mean ± SEM (n = 4).
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Decrease in DEPPD oxidation due to pretreatment of human serum with the GSH
peroxidase mimetic, ebselen. A) Samples were pretreated with ebselen for 6 min at
concentrations indicated. In separate experiments (not shown), pretreatment with 1 mmol/l
ebselen provided approximately the same loss of signal as 0.5 mmol/l, and was adopted as
the standard procedure. B) Addition of 1 mmol/l ebselen to samples after color formation
(Post) did not decrease color. Controls were the standard assay with serum plus Fe2+ and
DEPPD (None), and assay with serum pretreated with 1 mmol/l ebselen (Pre). C) Spectra
resulting from ebselen-pretreated serum compared to same serum without ebselen. D) A
typical ESR spectrum of free radical detection by CDMIO in the presesnce of tert-
butylhydroperoxide + Fe2+ which identifies both C- and O-centered radical adducts. E) An
ESR spectrum of serum + Fe2+ +CDMIO which shows mostly a signal typical of -O-
centered radicals. F) Preincubation of serum with ebselen prior to addition of Fe2+ +CDMIO
shows loss of signal from oxygen-centered radicals (Fig. 4F). Spectra for A-C are
representative of samples from at least 3 individuals. Other data are mean ± SEM (n = 4).
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Oxidation of DEPPD by the endoperoxide prostaglandin H2 (PGH2) and 16, 17-epoxy-21-
acetoxy-pregnenolone (Ep). Preliminary experiments were performed to determine
concentration ranges for assay with PGH2, Ep and styrene oxide. Results showed that 90
μmol/l PGH2 and 1 mmol/l Ep produced a signal but 1 mmol/l styrene oxide did not. A)
Standard 6-min assay with addition of 90 μmol/l PGH2 (PG) instead of serum. Pretreatment
with ebselen (Eb) or microsomal epoxide hydrolase (EH) eliminated signal. B) Spectrum
showing elimination of signal by pretreatment with EH. C. Standard 6-min assay with
addition of 1 mmol/l Ep instead of serum. Pretreatment with ebselen (Eb) decreased the
signal and with microsomal epoxide hydrolase (EH) largely eliminated the signal. C.
Spectrum showing signal generated by 1 mmol/l Ep and loss of signal by pretreatement with
EH. Bl, Blank.
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Comparison of human serum oxidants assayed by DEPPD oxidation with ebselen-pretreated
reference (ebs-ROS) to standard analysis without pretreatment (d-ROMs). Samples were
assayed by standard 6-min timed DEPPD oxidation in the presence of Fe2+ and compared to
results using matched serum samples pretreated with 1 mmol/l ebselen as references.
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Table 1
Comparison of the multiwell plate-adapted method for measurement of ROM using
DEPPD oxidation in the presence of Fe2+ to results obtained with the commercially
available FORT kit
Within day Between day
Method
FORT kit (Carr Units) (Low) 273 ± 31 270 ± 23
CV (%) 11 8.6
(High) 495 ± 5 485 ± 16
CV (%) 1.0 3.2
Overall CV (%, n=4) 6.0 5.8
Microplate (Carr Units) (Low) 295 ± 21 288 ± 20
CV (%) 7.1 6.8
(High) 478 ± 22 465 ± 19
CV (%) 5.0 4.8
Overall CV (%, n=4) 6.5 5.3
Microplate value as percentage of FORT value (n=4) 101 ± 4 99 ± 0.5
Clin Chim Acta. Author manuscript; available in PMC 2013 December 24.
